Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5) is a member of the polypeptide N-acetylgalactosamine-transferase family, possessing conserved catalytic domains found in glycosyltransferases but lacking a functional lectin domain and verified enzymatic activity in vitro. This protein is almost exclusively expressed in the testis and is essential for spermatid maturation and normal sperm motility, likely participating in processes such as protein loading into acrosomes and assembly of the ubiquitin-proteasome system at the sperm neck region. Genetic mutations leading to loss or dysfunction of GALNTL5 are associated with male infertility, especially due to asthenozoospermia (immotile sperm syndrome). Despite being an “enzyme-like” protein, direct transferase activity for GALNTL5 has not been demonstrated in vitro, leading it to be considered an inactive or atypical member of its enzyme family. There are currently no clinically established drug interactions, mechanisms of action, or established use as a biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polypeptide N-acetylgalactosaminyltransferase like 5 (GALNTL5).